Life Sciences Translation Services Market Undergoes Digital Evolution

The global life sciences translation services market was valued at USD 1.45 billion in 2023 and is anticipated to reach USD 2.55 billion by 2030, demonstrating a Compound Annual Growth Rate (CAGR) of 8.4% from 2024 to 2030. This projected growth is primarily attributed to the escalating demand for clinical trials, the increasing imperative for adherence to Good Clinical Practice (GCP) and regulatory compliance, and the ongoing globalization of the life sciences industry.

Within the extensive scope of the life sciences sector, translation and localization are indispensable. This includes, but is not limited to, the translation of regulatory documentation, Instructions for Use (IFUs), package labeling, and marketing collateral.

Key factors such as technological advancements in interpretation tools, a surging demand for interpretation services, and the rising need for culturally tailored medical marketing content are actively shaping this market. These elements are expected to significantly drive the adoption of translation services in the coming years. Furthermore, continuous innovations in translation technology, notably Neural Machine Translation (NMT) and Computer-Assisted Translation (CAT) tools enhanced by natural language processing (NLP), are increasingly bridging the gap between human and automated translations, thereby improving efficiency. For instance, a 2019 survey by ProZ revealed that 88% of full-time translators utilize CAT tools, with 76% employing multiple tools.

Key Market Insights:

• North American Dominance: The North America life sciences translation services market led globally in 2023, commanding the largest revenue share of 46.08%.
• U.S. Leadership in North America: Within the North American region, the U.S. market for life sciences translation services held the largest share in 2023.
• Technical Translation Segment: By type, the technical translation segment dominated the market with the largest revenue share of 39.45% in 2023.
• Technology/AI-Based Category: The technology/AI-based segment, by category, held the largest revenue share of 67.20% in 2023.

Order a free sample PDF of the Life Sciences Translation Services Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2023 Market Size: USD 1.45 Billion
• 2030 Projected Market Size: USD 2.55 Billion
• CAGR (2024-2030): 8.4%
• North America: Largest market in 2023
• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights:

The life sciences translation services market is characterized by significant fragmentation, with a multitude of service providers operating at a country-specific level to meet diverse local needs. This dynamic environment fosters intense competition, prompting both established and emerging players to actively pursue expansion into untapped markets to secure higher revenues. Among the prominent emerging players actively shaping this landscape are Summa Linguae Technologies, known for its AI-powered and human expertise-driven language solutions; Skrivanek, a global translation and localization company with a strong focus on specialized and medical content; and ProfLingva, a specialized medical translation agency. These companies are strategically establishing extensive dealer networks, building robust customer bases, and diversifying their product portfolios to gain a competitive edge. They are also investing in technological advancements and innovative production techniques to optimize efficiency and profitability.

Leading Companies:

• Conversis
• Morningside, Inc
• Crimson Interactive Inc.
• Welocalize Life Sciences
• ALM Translations Ltd
• Stepes
• Questel.
• BURG Translations

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The global life sciences translation services market is experiencing strong momentum, driven by the growing demand for regulatory compliance, multilingual clinical trials, and localized medical communications. Technological innovations such as Neural Machine Translation and Computer-Assisted Translation tools are enhancing the efficiency and quality of translation outputs. As the life sciences industry continues to expand globally, culturally nuanced and technically accurate translations have become a critical necessity. Regional markets like North America remain dominant, while Asia Pacific is emerging as a key growth region. Competitive dynamics are being shaped by specialized providers leveraging AI and strategic expansion to capture new market opportunities.